Colinz Laboratories Ltd has scheduled a meeting of the Board of Directors on Thursday, October 29, 2026. The meeting is convened pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The primary agenda items for the board meeting include:
- Consideration and approval of the Unaudited Financial Results of the Company for the Quarter and Half Year ended on September 30, 2026
- Any other business with permission of the Chair, if any
The company also confirmed that the Trading Window for dealing in the equity shares of the Company has been closed from October 01, 2026, in accordance with the Company's Code of Conduct for prevention of Insider Trading framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the communication of the financial results to the Stock Exchange.
This intimation serves as formal communication to the Bombay Stock Exchange (BSE Limited) and requests the exchange to take the information on record and bring it to the notice of all concerned parties.
- Director Identification Number: 11363910
- Company CIN: L2420014H1986PLC041128
- Corporate Office: A/101, Pratik Estate, Next to Fortis Hospital, Mulund Link Road, P.Box No. 17339, Mumbai-400078, India
- Contact: Email - colinzlabs@yahoo.com / colinzlabs@gmail.com, Mobile - 9137392123